A Phase I, Open-Label, Randomized, Crossover Trial in 20 Healthy Subjects to Investigate the Pharmacokinetic Interactions Between the Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Efavirenz; Telaprevir; Tenofovir disoproxil fumarate
- Indications Hepatitis C; HIV infections
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 16 Jun 2009 Actual end date (April 2009) added as reported by ClinicalTrials.gov.
- 16 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Feb 2009 Additional location identified as reported by ClinicalTrials.gov, last updated 27-2-2009.